story of the week
Outcomes Associated With HER2DX ERBB2 mRNA Expression in Patients With Advanced HER2+ MBC Treated With T-DM1
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the National Cancer Institute
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1
J. Natl. Cancer Inst 2022 Dec 28;[EPub Ahead of Print], F Brasó-Maristany, G Griguolo, N Chic, T Pascual, L Paré, J Maues, P Galván, MV Dieci, F Miglietta, T Giarratano, O Martínez-Sáez, M Marín-Aguilera, F Schettini, B Conte, L Angelats, M Vidal, B Adamo, M Muñoz, E Sanfeliu, B González, A Vivancos, P Villagrasa, JS Parker, CM Perou, P Conte, A Prat, V GuarneriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.